In-Silico testing and validation of Cardiovascular IMplantable devices Read more

SIMCor is a 3-year (2021-2023) Horizon 2020 research and innovation action developing a computational platform for in-silico development, validation and regulatory approval of cardiovascular implantable devices

Objective 1

Provide proof-of-validation for virtual cohorts and computer-based simulation of cardiovascular device implantation and performance

Objective 2

Develop standards and protocols for in-silico testing and validation of cardiovascular devices

Objective 3

Quantify the benefits of in-silico testing for healthcare, industry and society as a whole

Objective 4

Accelerate the integration of in-silico testing into the medical device regulatory approval process, the market and the clinics

Objective 5

Contribute to the European Open Science Cloud with data, virtual cohorts, simulation models, methodologies, standards and guidelines

Image credits: SimCardioTest.


Vestdijk, Eindhoven. Nanda Sluijsmans from Den Haag, Nederland, CC BY-SA 2.0, via Wikimedia Commons.

Visualisation of three different steps of the deployment simulation of a self-expanding TAVI device. Credits: Philips Research, Eindhoven, Netherlands. Licence: CC-BY 4.0

6-8 September 2022
GALA 2022

Bad Bevensen – Brückenstraße – Ilmenau by Frank Vincentz, CC BY-SA 3.0.



Das Postfuhramt (Berlin). Photo credits: Matthias Süßen, CC BY-SA 4.0, via Wikimedia Commons